Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia; Physiology Unit, Faculty of Medicine, AIMST University, 08100 Bedong, Kedah, Malaysia.
Department of Pre-clinical Sciences, Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman, 43000 Kajang, Selangor, Malaysia.
Cytokine. 2018 Nov;111:541-550. doi: 10.1016/j.cyto.2018.06.010. Epub 2018 Jun 14.
Endothelial barrier dysfunction leads to increased endothelial permeability and is an early step in the development of vascular inflammatory diseases such as atherosclerosis. Interferon-γ (IFN-γ), a proinflammatory cytokine, is known to cause increased endothelial permeability. However, the mechanisms by which IFN-γ disrupts the endothelial barrier have not been clarified. This study aimed to investigate how IFN-γ impairs the endothelial barrier integrity by specifically examining the roles of caldesmon, adherens junctions (AJs) and p38 mitogen-activated protein (MAP) kinase in IFN-γ-induced endothelial barrier dysfunction. IFN-γ exhibited a biphasic effect on caldesmon localization and both the structural organization and protein expression of AJs. In the early phase (4-8 h), IFN-γ induced the formation of peripheral caldesmon bands and discontinuous AJs, while AJ protein expression was unchanged. Interestingly, IFN-γ also stimulated caldesmon phosphorylation, resulting in actin dissociation from caldesmon at 8 h. Conversely, changes seen in the late phase (16-24 h) included cytoplasmic caldesmon dispersal, AJ linearization and junctional area reduction, which were associated with reduced membrane, cytoskeletal and total AJ protein expression. In addition, IFN-γ enhanced myosin binding to caldesmon at 12 h and persisted up to 24 h. Furthermore, inhibition of p38 MAP kinase by SB203580 did not reverse either the early or late phase changes observed. These data suggest that IFN-γ may activate signaling molecules other than p38 MAP kinase. In conclusion, our findings enhance the current understanding of how IFN-γ disrupts endothelial barrier function and reveal potential therapeutic targets, such as caldesmon and AJs, for the treatment of IFN-γ-associated vascular inflammatory diseases.
内皮屏障功能障碍导致内皮通透性增加,是动脉粥样硬化等血管炎症性疾病发展的早期步骤。干扰素-γ(IFN-γ),一种促炎细胞因子,已知可导致内皮通透性增加。然而,IFN-γ破坏内皮屏障的机制尚未阐明。本研究旨在通过专门研究钙调蛋白、黏附连接(AJs)和 p38 丝裂原激活蛋白(MAP)激酶在 IFN-γ 诱导的内皮屏障功能障碍中的作用,来研究 IFN-γ 如何损害内皮屏障完整性。IFN-γ 对钙调蛋白定位表现出双相作用,并且 AJs 的结构组织和蛋白表达均发生改变。在早期阶段(4-8 小时),IFN-γ 诱导形成周边钙调蛋白带和不连续的 AJs,而 AJ 蛋白表达不变。有趣的是,IFN-γ 还刺激钙调蛋白磷酸化,导致 8 小时时肌动蛋白与钙调蛋白分离。相反,在晚期阶段(16-24 小时)观察到的变化包括细胞质钙调蛋白弥散、AJ 线性化和连接区减少,这与膜、细胞骨架和总 AJ 蛋白表达减少有关。此外,IFN-γ 在 12 小时增强肌球蛋白与钙调蛋白的结合,并持续至 24 小时。此外,SB203580 抑制 p38 MAP 激酶并不能逆转观察到的早期或晚期变化。这些数据表明,IFN-γ 可能激活除 p38 MAP 激酶之外的信号分子。总之,我们的发现增强了对 IFN-γ 破坏内皮屏障功能的机制的理解,并揭示了潜在的治疗靶点,如钙调蛋白和 AJs,用于治疗 IFN-γ 相关的血管炎症性疾病。